Avalglucosidase alfa granted Promising Innovative Medicine (PIM) status for Pompe disease

Pompe disease is a rare genetically-inherited disorders which results in deficiency of acid alpha-glucosidase enzyme, leading to accumulation of glycogen in certain organs &tissues. PIM status for this enzyme replacement therapy was granted on basis of phase III COMET trial.

Source:

PharmaTimes